Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661b3ea63e73acc96731eb73625b1bc2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7d999bb6ab478a7ed29b45a75d9190d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-1101 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 |
filingDate |
2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e11d143d654d1d59885cad9424151c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e43504ec4fd963abc3a6c7fe19ef68d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e64f4a51f22377c9245fa715757067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b507582300a3f776bba0e324c59c36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95bd72ba79a0d9141a0355cacfca8d03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9c7524bae859538b3a9ad07c66741c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f62dc542b83980ed71d058780069740 |
publicationDate |
2009-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2018443-A2 |
titleOfInvention |
Compositions and methods for inhibiting expression of ikk-b gene |
abstract |
The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the IKK-B gene, comprising an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of the IKK-B gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression or activation of the IKK-B gene using the pharmaceutical composition; and methods for inhibiting the expression of the IKK-B gene in a cell. |
priorityDate |
2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |